Signaturefd, LLC Cellectis S.A. Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$3.45 - $8.77 $13,113 - $33,334	-3,801 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$8.01 - $12.84 $27,834 - $44,619	3,475 Added 1065.95%	3,801 $31,000
Q3 2021 Oct 28, 2021	BUY	$11.94 - $16.09 $3,498 - $4,714	293 Added 887.88%	326 $4,000
Q2 2021 Jul 26, 2021	BUY	$14.36 - $20.93 $473 - $690	33 New	33 $1,000
Q4 2020 Feb 11, 2021	SELL	$15.87 - $31.64 $650 - $1,297	-41 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$15.7 - $20.84 $643 - $854	41 New	41 $1,000
Q2 2020 Jul 30, 2020	SELL	$8.21 - $21.02 $2,569 - $6,579	-313 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$7.81 - $18.82 $2,444 - $5,890	313 New	313 $3,000

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.